Age . | n* . | Body weight (gm) . | Genotype . | Osteoblasts (/0.01mm2) . | % control . | Pvalue‡ . | BrdU+ (/0.01mm2) . | Labeling index (%) . | % control . | Pvalue‡ . |
---|---|---|---|---|---|---|---|---|---|---|
P7 | 5 | 4.2 | Control† | 31.9±2.2 | 7.9±1.3 | 24.7 | ||||
5 | 2.9 | Fgfr2cko | 31.0±1.7 | 97 | 0.4 | 6.3±0.6 | 20.2 | 82 | 0.035 | |
P15 | 4 | 8.7 | Control† | 22.8±3.3 | 5.6±0.6 | 24.4 | ||||
4 | 4.1 | Fgfr2cko | 19.4±3.7 | 85 | 0.2 | 3.6±0.4 | 18.5 | 76 | 0.0014 | |
P25 | 4 | 18.8 | Control† | 13.8±2.4 | 3.7±0.5 | 26.5 | ||||
4 | 9.7 | Fgfr2cko | 14.7±1.3 | 106 | 0.6 | 2.0±0.3 | 13.4 | 50 | 0.0011 |
Age . | n* . | Body weight (gm) . | Genotype . | Osteoblasts (/0.01mm2) . | % control . | Pvalue‡ . | BrdU+ (/0.01mm2) . | Labeling index (%) . | % control . | Pvalue‡ . |
---|---|---|---|---|---|---|---|---|---|---|
P7 | 5 | 4.2 | Control† | 31.9±2.2 | 7.9±1.3 | 24.7 | ||||
5 | 2.9 | Fgfr2cko | 31.0±1.7 | 97 | 0.4 | 6.3±0.6 | 20.2 | 82 | 0.035 | |
P15 | 4 | 8.7 | Control† | 22.8±3.3 | 5.6±0.6 | 24.4 | ||||
4 | 4.1 | Fgfr2cko | 19.4±3.7 | 85 | 0.2 | 3.6±0.4 | 18.5 | 76 | 0.0014 | |
P25 | 4 | 18.8 | Control† | 13.8±2.4 | 3.7±0.5 | 26.5 | ||||
4 | 9.7 | Fgfr2cko | 14.7±1.3 | 106 | 0.6 | 2.0±0.3 | 13.4 | 50 | 0.0011 |